Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-02-05

Clinical Trial Update: Treximet in Acute Migraine Headache: Assessing Cognitive Function [NA]

View source ↗

Summary

A clinical trial update on Treximet (sumatriptan/naproxen) in acute migraine headache, evaluating cognitive function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

Sponsor: Neurological Research Center | Conditions: Migraine Headache, Cognitive Impairment | NA | Status: UNKNOWN